Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01044758 · ClinicalTrials.gov registry record · Phase 2
Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
NCT01044758: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT01044758 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01044758, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
Study Summary
This research is being done to find out if daily use of the drug levetiracetam can improve memory function in individuals with memory problems like those associated with Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD).
Interventions
- DRUG Placebo
- DRUG Levetiracetam 62.5mg
- DRUG Levetiracetam 125mg
- DRUG Levetiracetam 250mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01044758
The ClinicalTrials.gov registry entry for NCT01044758 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01044758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01044758 about?
NCT01044758 is a clinical study titled "Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)". This research is being done to find out if daily use of the drug levetiracetam can improve memory function in individuals with memory problems like those associated with Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD).
What is the current status of trial NCT01044758?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2009-12. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01044758?
The interventions under investigation include: Placebo (DRUG), Levetiracetam 62.5mg (DRUG), Levetiracetam 125mg (DRUG), Levetiracetam 250mg (DRUG).
Who is sponsoring clinical trial NCT01044758?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.